Adrien Châtillon
FounderI am a serial entrepreneur (3+ startups), who has lived and worked in more than 8 countries. As the CEO of a medical-tech company, my goal is to democratize access to better and more affordable mental health therapeutics.
Browser storage is unavailable. Keep this page open and export your collection before leaving.

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application.
Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment.
Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.
I am a serial entrepreneur (3+ startups), who has lived and worked in more than 8 countries. As the CEO of a medical-tech company, my goal is to democratize access to better and more affordable mental health therapeutics.
I am a MD/PhD in neuroscience. Passionate about applying technology to solve nervous system disorders. Frustrated (but self-taught!) engineer, industrial designer, and artist.
Founded 2017 · Source
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.